Babcock International Group (BAB) H2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2026 earnings summary
22 Jun, 2026Executive summary
Delivered strong FY 2026 results, reaffirming medium-term guidance and highlighting differentiated defense and nuclear capabilities, with 80% of revenue from these sectors.
Leadership transition underway, with Harry Holt set to succeed David Lockwood as CEO, ensuring continuity and strategic momentum.
Strategic momentum supported by disciplined capital allocation and targeted investment, increasing shareholder returns.
Financial highlights
Organic revenue grew 8% year-over-year to £5.2bn, with underlying operating profit up 19% to £433m and EPS up 20%.
Operating profit margin improved by 70bps to 8.2% (excluding Type 31 charge); cash conversion at 84%, delivering £262m in free cash flow.
Dividend increased by 15% to 7.5p; £200m share buyback completed post year-end, with another £200m announced for FY27.
Net debt reduced to £23m, leverage at 0.2x, and BBB+ credit rating retained.
Type 31 program incurred a £140m charge due to higher-than-expected rectification costs, absorbed within medium-term guidance.
Outlook and guidance
Reaffirmed medium-term guidance: mid-single digit organic revenue growth, 9%+ margins, and 80%+ operating cash conversion.
FY 2027 revenue visibility at 70% as of April 1, with expectation to reach 90% under contract by half-year.
Strong medium and long-term opportunity set, aligned to structural growth in defense and nuclear markets.
Strategic priorities include operational performance, talent management, and disciplined capital allocation.
Latest events from Babcock International Group
- Strong growth and cash flow, offset by a GBP 140m Type 31 charge; outlook unchanged.BAB
H2 2026 TU19 May 2026 - Revenue set to reach £600m by 2030, driven by clean energy and robust market demand.BAB
Status Update3 Feb 2026 - Revenue and profit surged, with robust cash flow and reduced pension deficit despite Type 31 charge.BAB
H2 2024 TU3 Feb 2026 - Strong growth, margin expansion, and robust cash flow despite Type 31 programme loss.BAB
H2 20242 Feb 2026 - Q3 results show robust growth and margin gains, reinforcing confidence in FY26 targets.BAB
Q3 2026 TU23 Jan 2026 - Strong revenue and profit growth, robust cash flow, and reduced leverage support a positive outlook.BAB
H1 202514 Jan 2026 - Targeting 9%+ margins and mid-single-digit growth with a GBP 22bn+ pipeline and digital innovation.BAB
Investor Day 202531 Dec 2025 - Strong growth, margin expansion, and robust cash flow support a confident full-year outlook.BAB
H1 202621 Nov 2025 - Upgraded guidance, strong profit growth, and a £200m buyback highlight robust performance.BAB
H2 202512 Nov 2025